These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
163 related articles for article (PubMed ID: 17991677)
1. Prevention of atherosclerosis progression in asymptomatic healthy elderly. Lees RS Am J Clin Nutr; 2007 Nov; 86(5):1569S-71S. PubMed ID: 17991677 [TBL] [Abstract][Full Text] [Related]
2. Prescription of Lipid-Lowering and Antihypertensive Drugs Following Pictorial Information About Subclinical Atherosclerosis: A Secondary Outcome of a Randomized Clinical Trial. Sjölander M; Carlberg B; Norberg M; Näslund U; Ng N JAMA Netw Open; 2021 Aug; 4(8):e2121683. PubMed ID: 34410393 [TBL] [Abstract][Full Text] [Related]
8. Dyslipidemia Part 2: Review of Dyslipidemia Treatment in Patients With Noncoronary Vascular Disease. Gonzalez L; Helkin A; Gahtan V Vasc Endovascular Surg; 2016 Feb; 50(2):119-35. PubMed ID: 26983668 [TBL] [Abstract][Full Text] [Related]
9. Impact of Lipids on Cardiovascular Health: JACC Health Promotion Series. Ference BA; Graham I; Tokgozoglu L; Catapano AL J Am Coll Cardiol; 2018 Sep; 72(10):1141-1156. PubMed ID: 30165986 [TBL] [Abstract][Full Text] [Related]
10. Effects of niacin on glucose levels, coronary stenosis progression, and clinical events in subjects with normal baseline glucose levels (<100 mg/dl): a combined analysis of the Familial Atherosclerosis Treatment Study (FATS), HDL-Atherosclerosis Treatment Study (HATS), Armed Forces Regression Study (AFREGS), and Carotid Plaque Composition by MRI during lipid-lowering (CPC) study. Phan BA; Muñoz L; Shadzi P; Isquith D; Triller M; Brown BG; Zhao XQ Am J Cardiol; 2013 Feb; 111(3):352-5. PubMed ID: 23168285 [TBL] [Abstract][Full Text] [Related]
11. The phenomenon of atherosclerosis reversal and regression: Lessons from animal models. Chistiakov DA; Myasoedova VA; Revin VV; Orekhov AN; Bobryshev YV Exp Mol Pathol; 2017 Feb; 102(1):138-145. PubMed ID: 28108216 [TBL] [Abstract][Full Text] [Related]
12. Differential impacts of blood pressure and lipid lowering on regression of ventricular and arterial mass: the Stop Atherosclerosis in Native Diabetics Trial. Roman MJ; Howard BV; Howard WJ; Mete M; Fleg JL; Lee ET; Devereux RB Hypertension; 2011 Sep; 58(3):367-71. PubMed ID: 21788602 [TBL] [Abstract][Full Text] [Related]
13. Progression and regression of the atherosclerotic plaque. de Feyter PJ; Vos J; Deckers JW Eur Heart J; 1995 Aug; 16 Suppl I():26-30. PubMed ID: 8829954 [TBL] [Abstract][Full Text] [Related]
15. Dyslipidemia and prevention of atherosclerotic cardiovascular disease in the elderly. Lucchi T Minerva Med; 2021 Dec; 112(6):804-816. PubMed ID: 33949178 [TBL] [Abstract][Full Text] [Related]
16. The prevention and regression of atherosclerotic plaques: emerging treatments. Kalanuria AA; Nyquist P; Ling G Vasc Health Risk Manag; 2012; 8():549-61. PubMed ID: 23049260 [TBL] [Abstract][Full Text] [Related]
17. Impact of combined lipid lowering and blood pressure control on coronary plaque: myocardial ischemia treated by percutaneous coronary intervention and plaque regression by lipid lowering and blood pressure controlling assessed by intravascular ultrasonography (MILLION) study. Kawashiri MA; Sakata K; Hayashi K; Gamou T; Kanaya H; Miwa K; Ueda K; Higashikata T; Mizuno S; Michishita I; Namura M; Nitta Y; Katsuda S; Okeie K; Hirase H; Tada H; Uchiyama K; Konno T; Ino H; Nagase K; Yamagishi M; Heart Vessels; 2017 May; 32(5):539-548. PubMed ID: 27798731 [TBL] [Abstract][Full Text] [Related]
18. Biologic plausibility, cellular effects, and molecular mechanisms of eicosapentaenoic acid (EPA) in atherosclerosis. Borow KM; Nelson JR; Mason RP Atherosclerosis; 2015 Sep; 242(1):357-66. PubMed ID: 26253795 [TBL] [Abstract][Full Text] [Related]
19. [Proposal for a diagnostic and therapeutic care pathway of the Piedmont Region on lipid-lowering and antithrombotic treatment in patients with peripheral arterial disease]. Patti G; Varbella F; Gaggiano A; Mennuni M; Annibali G; Celentani D; Del Nevo F; Piazza S; Musumeci G G Ital Cardiol (Rome); 2023 May; 24(5):344-354. PubMed ID: 37102347 [TBL] [Abstract][Full Text] [Related]
20. Long-term use of lipid-lowering drugs slows progression of carotid atherosclerosis: the Tromso study 1994 to 2008. Herder M; Arntzen KA; Johnsen SH; Eggen AE; Mathiesen EB Arterioscler Thromb Vasc Biol; 2013 Apr; 33(4):858-62. PubMed ID: 23393396 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]